
2024. Drawing as a Way of Knowing: How a Mapping Model Assists Preoperative Evaluation of Patients with Thyroid Carcinoma.  J Clin Med 13.
,2024. The pathologist counts-so many variables in the risk stratification of thyroid cancers.  J Clin Endocrinol Metab.
,2023. International Expert Consensus on US Lexicon for Thyroid Nodules.  Radiology 309(1):e231481
,2023. A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.  Thyroid 33(11):1318-1326
,2023. Laterocervical lymph node metastases from suspected thyroidal primary site that turned out to be metastases of lung cancer: A case report.  Clin Case Rep 11(7):e7417
,2023. Metabolic adverse events of multitarget kinase inhibitors: a systematic review.  Endocrine 81(1):16-29
,2023. Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach.  J Endocrinol Invest 46(11):2327-2330
,2023. The role of miR-139-5p in radioiodine-resistant thyroid cancer.  J Endocrinol Invest 46(10):2079-2093
,2023. A Reappraisal of Suspicious Sonographic Features of Thyroid Nodules: Shape Is Not an Independent Predictor of Malignancy.  J Clin Endocrinol Metab 108(9):e816-e822
,2023. A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study.  J Clin Endocrinol Metab 108(8):1921-1928
,2023. The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations.  Endocrine 79(1):45-48
,2022. Establishment and maintenance of thyroid organoids from human cancer cells.  STAR Protoc 3(2):101393
,2022. Non-Marked Hypoechogenic Nodules: Multicenter Study on the Thyroid Malignancy Risk Stratification and Accuracy Based on TIRADS Systems Comparison.  Medicina (Kaunas) 58.
,2022. US-Elastography With Different Techniques for Thyroid Nodule Characterization: Systematic Review and Meta-analysis.  Front Oncol 12:845549
,2022. Diagnostic accuracy of ultrasonographic features in detecting thyroid cancer in the transition age: a meta-analysis.  Eur Thyroid J 11.
,2022. New hope for patients with BRAF V600E-mutant anaplastic thyroid cancer: lights and shadows.  Ann Palliat Med 11(8):2796-2801
,2022. The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment.  Endocrine 78(2):387-391
,2022. Artificial Intelligence for Thyroid Nodule Characterization: Where Are We Standing?  Cancers (Basel) 14.
,2022. Precision oncology for RET-related tumors.  Front Oncol 12:992636
,2022. Prevalence of Thyroid Nodules and Thyroid Cancer in Individuals with a First-Degree Family History of Non-Medullary Thyroid Cancer: A Cross-Sectional Study Based on Sonographic Screening.  Thyroid 32(11):1392-1401
,2021. Selective Use of Radioactive Iodine Therapy for Papillary Thyroid Cancers With Low or Lower-Intermediate Recurrence Risk.  J Clin Endocrinol Metab 106(4):e1717-e1727
,2021. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.  Thyroid 31(2):264-271
,2021. Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer.  Thyroid 31(2):224-232
,2021. The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis.  Rev Endocr Metab Disord 22(2):453-460
,2021. Management of cytologically indeterminate thyroid nodules: primum non nocere.  Pol Arch Intern Med 131.
,2021. Molecular analysis of fine-needle aspiration cytology in thyroid disease: where are we?  Curr Opin Otolaryngol Head Neck Surg 29(2):107-112
,2021. TIRADS, SRE and SWE in INDETERMINATE thyroid nodule characterization: Which has better diagnostic performance?  Radiol Med 126(9):1189-1200
,2021. Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature.  Diagnostics (Basel) 11.
,2021. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).  Thyroid 31(12):1814-1821
,2021. Preoperative Ultrasonography in the Evaluation of Suspected Familial Non-Medullary Thyroid Cancer: Are We Able to Predict Multifocality and Extrathyroidal Extension?  J Clin Med 10.
,2020. Molecular defects in thyroid dysgenesis.  Clin Genet 97(1):222-231
,2020. Comment on: BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.  Clin Endocrinol (Oxf) 92(5):482-483
,2020. Screening for differentiated thyroid cancer in selected populations.  Lancet Diabetes Endocrinol 8(1):81-88
,2020. Clinically Silent Thyroid Cancers: Drop Those Needles and Scalpels!  J Clin Endocrinol Metab 105.
,2020. Risk of Kidney Dysfunction IN Nafld.  Curr Pharm Des 26(10):1045-1061
,2020. Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification.  Cancers (Basel) 12.
,2020. Diagnostic Performance of Neck Ultrasonography in the Preoperative Evaluation for Extrathyroidal Extension of Suspicious Thyroid Nodules.  World J Surg 44(8):2669-2674
,2020. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference.  Radiol Med 125(4):406-415
,2020. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma.  Endocrine 68(1):230-232
,2020. Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach.  J Surg Oncol 121(6):958-963
,2020. Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?  Cancer Cytopathol 128(4):250-259
,2020. Correction to: Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma.  Endocrine 68(1):248
,2020. Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?  Endocrine 68(3):485-488
,2020. Cancer Care During COVID-19 Era: The Quality of Life of Patients With Thyroid Malignancies.  Front Oncol 10:1128
,2020. Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid.  Cancers (Basel) 12.
,2020. Performance of EU-TIRADS in malignancy risk stratification of thyroid nodules: a meta-analysis.  Eur J Endocrinol 183(3):255-264
,2020. Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue.  Endocrine 69(2):451-455
,2020. Sonographic Risk Stratification Systems for Thyroid Nodules as Rule-Out Tests in Older Adults.  Cancers (Basel) 12.
,2020. Contemporary Thyroid Nodule Evaluation and Management.  J Clin Endocrinol Metab 105(9):2869-83
,2020. Computer-aided diagnostic system for thyroid nodule sonographic evaluation outperforms the specificity of less experienced examiners.  J Ultrasound 23(2):169-174
,2020. Fournier's gangrene during lenvatinib treatment: A case report.  Mol Clin Oncol 12(6):588-591
,2020. Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules.  Endocrine 68(2):458-465
,2020. Taller-Than-Wide Shape: A New Definition Improves the Specificity of TIRADS Systems.  Eur Thyroid J 9(2):85-91
,2019. Thyroid hormone therapy in differentiated thyroid cancer.  Endocrine 66(1):43-50
,2019. Lack of association between obesity and aggressiveness of differentiated thyroid cancer.  J Endocrinol Invest 42(1):85-90
,2019. Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study.  Endocrine 66(3):557-562
,2019. Thyroid Cancer Patients With No Evidence of Disease: The Need for Repeat Neck Ultrasound.  J Clin Endocrinol Metab 104(11):4981-4989
,2019. Nodular Thyroid Disease in the Era of Precision Medicine.  Front Endocrinol (Lausanne) 10:907
,2019. Prospective Evaluation of Semiquantitative Strain Ratio and Quantitative 2D Ultrasound Shear Wave Elastography (SWE) in Association with TIRADS Classification for Thyroid Nodule Characterization.  Ultraschall Med 40(4):495-503
,2019. Indeterminate thyroid nodules (TIR3A/TIR3B) according to the new Italian reporting system for thyroid cytology: A cytomorphological study.  Cytopathology 30(5):475-484
,2019. Is thyroid nodule location associated with malignancy risk?  Ultrasonography 38(3):231-235
,2019. Reducing the Number of Unnecessary Thyroid Biopsies While Improving Diagnostic Accuracy: Toward the "Right" TIRADS.  J Clin Endocrinol Metab 104(1):95-102
,2019. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.  J Endocrinol Invest 42(12):1485-1490
,2018. Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management.  Lancet Diabetes Endocrinol 6(6):500-514
,2018. 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2).  Endocr Relat Cancer 25(3):L7-L11
,2018. Interobserver agreement of various thyroid imaging reporting and data systems.  Endocr Connect 7(1):1-7
,2018. Recent advances in managing differentiated thyroid cancer.  F1000Res 7:86
,2018. The Diagnosis and Management of Thyroid Nodules: A Review.  JAMA 319(9):914-924
,2018. Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.  Dig Dis Sci 63(7):1970-1976
,2018. Follow-up of differentiated thyroid cancer - what should (and what should not) be done.  Nat Rev Endocrinol 14(9):538-551
,2018. Sonographically Estimated Risks of Malignancy for Thyroid Nodules Computed with Five Standard Classification Systems: Changes over Time and Their Relation to Malignancy.  Thyroid 28(9):1190-1197
,2018. Thyroid nodule recurrence following lobo-isthmectomy: incidence, patient's characteristics, and risk factors.  J Endocrinol Invest 41(12):1469-1475
,2018. A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency.  PLoS Genet 14(10):e1007678
,2018. Sonographic Presentation of Metastases to the Thyroid Gland: A Case Series.  J Endocr Soc 2(8):855-859
,2017. Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up.  J Endocr Soc 1(1):3-13
,2017. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.  Thyroid 27(12):1490-1497
,2017. Temporal Changes in Thyroid Nodule Volume: Lack of Effect on Paranodular Thyroid Tissue Volume.  Thyroid 27(11):1378-1384
,2017. MicroRNA-based molecular classification of papillary thyroid carcinoma.  Int J Oncol 50(5):1767-1777
,2017. Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules.  Endocrine 57(2):256-261
,2016. Severe hypoglycemia in patients with known diabetes requiring emergency department care: A report from an Italian multicenter study.  J Clin Transl Endocrinol 5:46-52
,2016. Risk Stratification of Neck Lesions Detected Sonographically During the Follow-Up of Differentiated Thyroid Cancer.  J Clin Endocrinol Metab 101(8):3036-44
,2015. A comprehensive score to diagnose Hashimoto's thyroiditis: a proposal.  Endocrine 49(2):361-5
,2015. Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology.  Head Neck 37(2):260-4
,2015. Association of thyroid diseases with primary extra-thyroidal malignancies in women: results of a cross-sectional study of 6,386 patients.  PLoS One 10(3):e0122958
,2015. Influence of thyrotropin and thyroid volume on basal serum calcitonin.  Exp Clin Endocrinol Diabetes 123(1):44-7
,2015. Grey-Scale Analysis Improves the Ultrasonographic Evaluation of Thyroid Nodules.  Medicine (Baltimore) 94(27):e1129
,2014. Thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy.  J Clin Endocrinol Metab 99(6):1970-82
,2013. Total thyroidectomy for Graves' disease treatment.  Clin Ter 164(3):193-6
,2013. Thyroid function in infertile patients undergoing assisted reproduction.  Am J Reprod Immunol 70(4):336-41
,2013. Intrinsic factors affecting adequacy of thyroid nodule fine-needle aspiration cytology.  Clin Endocrinol (Oxf) 78(1):141-4
,2012. Thyroid diseases in women with breast cancer.  Clin Ter 163(6):e401-4
,2012. Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis.  Endocr Relat Cancer 19(3):345-9
,2011. Knowledge of iodoprophylaxis and iodized salt consumption among medical students in Italy.  Clin Ter 162(5):409-11
,2011. Therapy of hyperthyroidism in pregnancy and breastfeeding.  Obstet Gynecol Surv 66(6):378-85
,2010. Medical treatment of hyperthyroidism: state of the art.  Exp Clin Endocrinol Diabetes 118(10):678-84
,2010. Diagnostic accuracy of rhTSH test with neck ultrasonography in differentiated thyroid cancer follow-up.  Exp Clin Endocrinol Diabetes 118(8):554-6
,2009. Medullary thyroid carcinoma and tuberous sclerosis.  Endocr Pathol 20(2):141-4
,Publication list retrieved from NCBI using ImpactPubs
.